SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001165527-18-000158
Filing Date
2018-07-25
Accepted
2018-07-24 18:15:20
Documents
40
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 g8598.htm 10-Q 447135
2 ex31.htm EX-31 13548
3 ex32.htm EX-32 4815
  Complete submission text file 0001165527-18-000158.txt   2355692

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT clcs-20170630.xml EX-101.INS 364271
5 XBRL TAXONOMY EXTENSION SCHEMA clcs-20170630.xsd EX-101.SCH 27742
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clcs-20170630_cal.xml EX-101.CAL 37981
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clcs-20170630_def.xml EX-101.DEF 115947
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE clcs-20170630_lab.xml EX-101.LAB 176664
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clcs-20170630_pre.xml EX-101.PRE 155335
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 18967296
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1